Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-07-21 @ 3:43 AM
Study NCT ID:
NCT02651168
Status:
UNKNOWN
Last Update Posted:
2016-01-08
First Post:
2016-01-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
Sponsor:
Unity Health Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Protocol B SMH Aflibercept
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None